Session Details
[1-O]Oral Presentation
Mon. Mar 16, 2026 3:50 PM - 5:20 PM JST
Mon. Mar 16, 2026 6:50 AM - 8:20 AM UTC
Mon. Mar 16, 2026 6:50 AM - 8:20 AM UTC
Room 10(B102)
Chair:Chiho Sumi-Ichinose(Fujita Health University), Masato Katsuyama(Kyoto Prefectural University of Medicine)
[1-O-18]A novel 3D in vitro MASH model for evaluating anti-fibrotic drug efficacy
*Toshihiko Maekawa1, Ayu Inoue1, Aya Sugai1, Hiroyuki Kobayashi2, Yuya Asano2, Saeko Hamanaka2 (1. Cyfuse Biomedical K.K., 2. Nihon Bioresearch Inc.)
[1-O-19]Intracellular cellular mechanism of nuclear localisation of urocortin I in HeLa cells.
*Keiichi Ikeda1 (1. Core Research Facilities for Basic Science, Research Centre for Medical Sciences, The Jikei University School of Medicine)
[1-O-20]Functional Screening Identifies Novel RNA-Binding Proteins as Therapeutic Targets in Cancer
*Hiroaki Konishi1, Takahiro Sasaki1, Katsuyoshi Ando1, Mikihiro Fujiya1 (1. Asahikawa Medical University)
[1-O-21]Intestinal BH4 metabolism regulation in quinonoid dihydropteridine reductase deficient mice
*Yui Suganuma1, Taiki Kano1, Kazuhisa Ikemoto1, Chiho Sumi-Ichinose1, Hiroshi Ichinose2, Kazunao Kondo1 (1. Fujita Health Univ., 2. Science Tokyo)
[1-O-22]Harmonization of reactive oxygen species (ROS) in the Adverse Outcome Pathway (AOP) framework: Outcomes from the Mystery of ROS consortium
*Shihori Tanabe1, Vinita Chauhan2, Carole Yauk3, Marcus Cooke4, Young-Jun Kim5, You Song6 (1. National Institute of Health Sciences, Japan, 2. Health Canada, Canada, 3. University of Ottawa, Canada, 4. University of South Florida, USA, 5. Korean Institute of Science and Technology (KIST) Europe, Germany, 6. Norwegian Institute for Water Research (NIVA), Norway)
[1-O-23]Reagents that inhibit clioquinol-induced cell death
*Masato Katsuyama1 (1. Kyoto Prefectural University of Medicine)
